These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8286831)

  • 1. Biloma during steroid therapy for minimal change nephrotic syndrome.
    Ohtake T; Kimura M; Yoshii S; Ikegaya N; Takayanagi S; Hishida A; Kaneko E
    Intern Med; 1993 Jul; 32(7):543-6. PubMed ID: 8286831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous improvement of minimal-change nephrotic syndrome and anemia with steroid therapy.
    Yabana M; Kihara M; Toya Y; Tamura K; Matsumoto K; Takagi N; Kamijo S; Ishii M; Umemura S
    Nephron; 1999 Jan; 81(1):84-8. PubMed ID: 9884426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectiveness of the treatment of a nephrotic form of glomerulonephritis in children].
    Kanatbaeva AB; Mustafina SM; Shparvasser VV; Ti VD
    Pediatriia; 1991; (7):89-91. PubMed ID: 1754335
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic nephrotoxicity limits successful use of Tacrolimus in the management of adult steroid-dependent minimal change disease.
    Ramachandran R; Kumar D A P; Nada R; Jha V; Gupta KL; Kohli HS
    Nephrology (Carlton); 2015 May; 20(5):384-5. PubMed ID: 25872662
    [No Abstract]   [Full Text] [Related]  

  • 5. Amelioration of the adverse effects of prednisolone by rituximab treatment in adults with steroid-dependent minimal-change nephrotic syndrome.
    Miyabe Y; Takei T; Iwabuchi Y; Moriyama T; Nitta K
    Clin Exp Nephrol; 2016 Feb; 20(1):103-10. PubMed ID: 26138356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pembrolizumab-associated nephrotic syndrome recovered from transient hemodialysis in a patient with lung cancer.
    Ishibuchi K; Iwakura T; Kaneko M; Fukasawa H; Furuya R
    CEN Case Rep; 2020 Aug; 9(3):215-219. PubMed ID: 32170578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the effectiveness of various programs of active therapy of primary glomerulonephritis with nephrotic syndrome in children].
    Sten'shinskaia EV
    Pediatriia; 1991; (7):86-9. PubMed ID: 1754334
    [No Abstract]   [Full Text] [Related]  

  • 8. [Steroid-Dependent Nephrotic Syndrome Due to Minimal Change Glomerulonephritis Treated with Rituximab].
    Cristiano F; Verratti V; Di Matteo G; Fulle S; Cristiano J; D'Angelo B; Caravelli L; Posari C; Schiazza A; Piano A
    G Ital Nefrol; 2024 Feb; 41(1):. PubMed ID: 38426681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrohematuria with electron-dense deposits in a 14-year-old boy with minimal change nephrotic syndrome.
    Filler G; Robb I; Carpenter B
    Pediatr Nephrol; 2001 Jan; 16(1):91-3; discussion 94-6. PubMed ID: 11198614
    [No Abstract]   [Full Text] [Related]  

  • 10. Rituximab therapy for steroid-dependent minimal change nephrotic syndrome.
    Gilbert RD; Hulse E; Rigden S
    Pediatr Nephrol; 2006 Nov; 21(11):1698-700. PubMed ID: 16932900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid-sensitive nephrotic syndrome and minimal-change nephropathy associated with autosomal-recessive polycystic kidney disease.
    Révai T; Harmos G
    Clin Nephrol; 1999 Jul; 52(1):65. PubMed ID: 10442502
    [No Abstract]   [Full Text] [Related]  

  • 12. Abdominal involvement in minimal change nephrotic syndrome.
    Kagaya S; Nagasawa T
    Clin Exp Nephrol; 2018 Apr; 22(2):481-482. PubMed ID: 28733945
    [No Abstract]   [Full Text] [Related]  

  • 13. Reversible acute renal failure in idiopathic nephrotic syndrome with minimal change nephropathy.
    Dash SC; Malhotra KK; Sharma RK; Bhuyan UN
    J Assoc Physicians India; 1982 Jun; 30(6):399-401. PubMed ID: 7169462
    [No Abstract]   [Full Text] [Related]  

  • 14. Stability of remission in minimal lesion nephrotic syndrome after treatment with prednisolone and cyclophosphamide.
    Dundon S; O'Callaghan U; Raftery J
    Int J Pediatr Nephrol; 1980 Mar; 1(1):22-5. PubMed ID: 7343524
    [No Abstract]   [Full Text] [Related]  

  • 15. Pneumatosis intestinalis associated with immune-suppressive agents in a case of minimal change disease.
    Han BG; Lee JM; Yang JW; Kim MS; Choi SO
    Yonsei Med J; 2002 Oct; 43(5):686-9. PubMed ID: 12402387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of minimal change nephrotic syndrome complicated by Kimura disease treated with rituximab.
    Yoshida R; Hara Y; Fujii Y; Matuda H
    CEN Case Rep; 2023 Nov; 12(4):368-373. PubMed ID: 36809634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of two unconventional agents in steroid-dependent nephrotic children.
    Donia AF; Ammar HM; El-Agroudy Ael-B; Moustafa Fel-H; Sobh MA
    Pediatr Nephrol; 2005 Oct; 20(10):1420-5. PubMed ID: 16047223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrotic syndrome preceding Hodgkin's disease by 42 months.
    Huisman RM; de Jong PE; de Zeeuw D; van Imhoff GW; van der Hem GK
    Clin Nephrol; 1986 Dec; 26(6):311-3. PubMed ID: 3802598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Massive pulmonary embolism occurring with corticosteroid and diuretics therapy in a minimal-change nephrotic patient.
    Shimamatsu K; Onoyama K; Maeda T; Ohryoji F; Fujimi S; Omae T
    Nephron; 1982; 32(1):78-9. PubMed ID: 7177283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of the effectiveness of bolus doses of prednisolone in steroid-resistant and steroid-dependent nephrotic syndrome in children].
    Kryński J; Wyszyńska T
    Pediatr Pol; 1985 Feb; 60(2):163-8. PubMed ID: 3895148
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.